Pediatric blood & cancer

Improving Completion Rates of Transcranial Doppler Ultrasounds in Children With Sickle Cell Disease Using Quality Improvement Efforts: In-Clinic versus Population-Based Assessments.

Pediatric blood & cancer

Vissa M, Parikh P, McCulloch C, Bhasin N, Cabana MD, Chung J, Marsh A, Wong T, Treadwell M, Bardach NS

Zinc deficiency and its association with treatment-related toxicity in children with cancer.

Pediatric blood & cancer

Chung JH, Phalke N, Hastings C, Killilea DW, Feusner JH, Fung EB

Epidemiologic and clinical characteristics of nontransfusion-dependent thalassemia in the United States.

Pediatric blood & cancer

Vichinsky E, Cohen A, Thompson AA, Giardina PJ, Lal A, Paley C, Cheng WY, McCormick N, Sasane M, Qiu Y, Kwiatkowski JL

Long-term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5-year observational study (ENTRUST).

Pediatric blood & cancer

Vichinsky E, El-Beshlawy A, Al Zoebie A, Kamdem A, Koussa S, Chotsampancharoen T, Bruederle A, Gilotti G, Han J, Elalfy M

Emergency department utilization by Californians with sickle cell disease, 2005-2014.

Pediatric blood & cancer

Paulukonis ST, Feuchtbaum LB, Coates TD, Neumayr LD, Treadwell MJ, Vichinsky EP, Hulihan MM

Point-of-care end-tidal carbon monoxide reflects severity of hemolysis in sickle cell anemia.

Pediatric blood & cancer

Lal A, Patterson L, Goldrich A, Marsh A

Renal medullary carcinoma in an adolescent with sickle cell anemia.

Pediatric blood & cancer

Marsh A, Golden C, Hoppe C, Quirolo K, Vichinsky E

The palatability and tolerability of deferasirox taken with different beverages or foods.

Pediatric blood & cancer

Goldberg SL, Giardina PJ, Chirnomas D, Esposito J, Paley C, Vichinsky E

Pages